Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MVD-1 by Eolo Pharma for Obesity: Likelihood of Approval
MVD-1 is under clinical development by Eolo Pharma and currently in Phase I for Obesity. According to GlobalData, Phase I...